CAPTRUST FINANCIAL ADVISORS - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 171 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$17,000
-37.0%
1,700
-22.7%
0.00%
Q1 2022$27,000
-46.0%
2,2000.0%0.00%
Q4 2021$50,000
+2.0%
2,2000.0%0.00%
Q3 2021$49,000
+69.0%
2,2000.0%0.00%
Q2 2021$29,000
-47.3%
2,200
-47.6%
0.00%
-100.0%
Q1 2021$55,000
+83.3%
4,200
+90.9%
0.00%
Q4 2020$30,000
-6.2%
2,2000.0%0.00%
-100.0%
Q3 2020$32,000
-8.6%
2,2000.0%0.00%0.0%
Q2 2020$35,000
+191.7%
2,2000.0%0.00%
Q3 2019$12,000
-14.3%
2,2000.0%0.00%
-100.0%
Q2 2019$14,0000.0%2,2000.0%0.00%0.0%
Q1 2019$14,0002,2000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders